Live Cell Imaging of Chromosome Segregation During Mitosis
March 14th, 2018
8.8K views
This protocol describes an easy and convenient method to label and visualize live chromosomes in mitotic cells using Histone2B-GFP BacMam 2.0 label and a spinning disc confocal microscopy system.
Overview
This protocol describes a method to label and visualize live chromosomes in mitotic cells using Histone2B-GFP BacMam 2.0 and spinning disc confocal microscopy. This technique allows researchers to study chromosome segregation in cultured cells.
Key Study Components
Area of Science
- Cell Biology
- Microscopy
- Chromosome Dynamics
Background
- Live imaging of chromosomes is crucial for understanding mitosis.
- Histone2B-GFP provides a fluorescent marker for visualization.
- Spinning disc confocal microscopy enhances imaging quality.
- This method can be applied to various genetic and pharmacological studies.
Purpose of Study
- To visualize live chromosomes during mitosis.
- To assess the impact of genetic modifications on chromosome behavior.
- To evaluate drug effects on chromosome segregation.
Methods Used
- Labeling of chromosomes with Histone2B-GFP BacMam 2.0.
- Use of spinning disc confocal microscopy for imaging.
- Synchronization of mouse embryonic fibroblasts (MEFs) in G0/G1 phase.
- Incubation of MEFs in specific growth medium conditions.
Main Results
- Successful labeling of live chromosomes in mitotic MEFs.
- Clear visualization of chromosome dynamics during cell division.
- Demonstration of the method's ease and convenience.
- Potential applications in genetic and drug treatment studies.
Conclusions
- This method provides a reliable approach for live chromosome imaging.
- It facilitates the study of chromosome behavior under various conditions.
- The technique is accessible for researchers in cell biology.
Frequently Asked Questions
What is the main advantage of this method?
The main advantage is its ease and convenience for labeling and visualizing live chromosomes.
What type of cells are used in this protocol?
Mouse embryonic fibroblasts (MEFs) are used for this experiment.
How are the MEFs prepared for imaging?
MEFs are synchronized in G0/G1 phase and incubated in a specific growth medium.
What imaging system is utilized?
A spinning disc confocal microscopy system is used for imaging.
Who demonstrates the live imaging procedure?
Doctor Kazuyo Takeda demonstrates the procedure.
What is the purpose of using Histone2B-GFP?
Histone2B-GFP is used to label chromosomes for visualization during mitosis.
Executive Industry Relevance
Live chromosome imaging enables direct observation of mitotic fidelity, a critical determinant of genomic stability in cell-based therapies and disease models. By visualizing lagging chromosomes and segregation errors in real time, this method supports mechanistic de-risking of targets involved in cell cycle control, such as phosphatases and checkpoint regulators. The approach provides predictive confidence in assessing chromosomal integrity, informing go/no-go decisions in preclinical development and cell therapy manufacturing.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by linking phosphatase activity to spindle assembly checkpoint function and chromosomal segregation fidelity.
- Operational Value: Enables functional validation of targets like PP2A-B56γ through direct phenotypic readout of mitotic progression and error rates.
Screening & Assay Development
- Scientific Value: Generates quantitative, time-resolved data on chromosome lagging and mis-segregation as phenotypic endpoints for compound or genetic screening.
- Operational Value: Standardizes live-cell imaging workflows with reproducible transfection, synchronization, and imaging parameters for assay readiness.
Translational & Preclinical Research
- Scientific Value: Links mitotic defects to genomic instability, supporting translational biomarker relevance in cancer and cell therapy quality assessment.
- Operational Value: Enables continuity from target discovery through preclinical validation by monitoring chromosomal fidelity across genetic backgrounds and treatment conditions.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target validation to preclinical evaluation, where chromosomal segregation serves as a functional readout of pathway activity and cellular health.
- Discovery Biology: Supports hypothesis testing of kinase/phosphatase networks in mitotic control by visualizing downstream chromosomal consequences.
- Screening: Delivers assay-ready, quantitative outputs on mitotic progression and error frequency to compare genetic or drug-induced conditions.
- Analytics: Enables measurement of lagging chromosomes and mitotic duration as statistical readouts for comparing experimental groups.
- Translational Research: Connects mechanistic findings to preclinical relevance by associating segregation errors with genomic instability in disease models.
- Enterprise Reuse: Establishes a reusable imaging platform applicable across cell lines, genetic models, and treatment paradigms for sustained discovery value.
Operational & Enterprise Impact
- Scientific Value: Provides predictive confidence in target validation by reducing ambiguity in mechanistic links between cell cycle regulators and chromosomal fidelity.
- Operational Value: Delivers standardized, reproducible imaging with defined transfection, synchronization, and microscopy parameters.
- Strategic Value: Improves go/no-go decisions by quantifying chromosomal error rates that correlate with genomic instability and transformation risk.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on their impact on mitotic fidelity and downstream genomic integrity.
Implementation Considerations
- Requires expertise in live-cell imaging, transfection, and mitotic cell synchronization.
- Dependent on spinning disc confocal microscopy with environmental control and appropriate objectives.
- Necessitates standardization of transfection efficiency, nocodazole dosing, and imaging duration across experiments.
- Adaptation to primary or stem cells may require optimization of BacMam toxicity and expression levels.
- Limited by transient expression window (up to five days), constraining longitudinal studies.
Biopharma FAQs
Why does monitoring lagging chromosomes matter for target validation?
Lagging chromosomes indicate spindle assembly checkpoint failure and genomic instability, providing a direct phenotypic readout to validate targets involved in mitotic regulation. Observing increased lagging in PP2A-B56γ-deficient cells links phosphatase activity to checkpoint fidelity, supporting mechanistic de-risking. This enables confident assessment of whether a target modulates chromosomal segregation accuracy.
How does isolating the nocodazole washout step fit the discovery pipeline?
The nocodazole washout allows synchronized release from metaphase arrest, enabling controlled entry into anaphase to test checkpoint override and chromosomal segregation fidelity. This step isolates the variable of checkpoint adaptation, which is critical for evaluating genetic or pharmacological effects on mitotic progression. It supports hypothesis-driven screening by standardizing the mitotic entry point across conditions.
What do quantitative measurements of mitotic duration and chromosome errors enable?
Quantitative tracking of mitotic duration and frequency of lagging chromosomes provides statistical power to compare conditions, such as wild-type versus knockout MEFs. These measurements enable objective assessment of checkpoint strength and segregation accuracy, supporting data-driven decisions in target validation. The method outputs countable events and timing data suitable for statistical analysis and hit selection in screening campaigns.
Why do replication requirements matter for cross-functional collaboration?
Replicating imaging across multiple cells and experiments ensures that observed segregation defects are consistent and not due to variability in transfection or cell state. Consistent results across replicates build confidence in target phenotypes, enabling alignment between discovery, assay development, and preclinical teams. Standardized replication supports technology transfer and assay validation across sites.
What statistical analysis capabilities are required before implementation?
Implementation requires the ability to quantify lagging chromosomes per cell and mitotic duration across populations to apply statistical tests such as t-tests or ANOVA. These capabilities enable comparison of experimental groups and determination of significance in chromosomal segregation defects. Basic image analysis tools for counting and timing are sufficient to derive actionable data from the imaging output.
